Preservation of Renal Function Following Partial or Radical Nephrectomy Using 24-Hour Creatinine Clearance

European Urology

Volumn 54, Issue 1, 2008, Pages 143-152

  Clark, Aaron T D ^a   Breau, Rodney H ^a   Morash, Chris ^a   Fergusson, Dean ^b   Doucette, Steve ^b   Cagiannos, Ilias ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

Creatinine; Creatinine clearance; Nephrectomy; Nephron sparing; Partial nephrectomy; Renal function; Renal function tests

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER PATIENT; CANCER SURGERY; COMPUTER PROGRAM; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIABETES MELLITUS; DRUG USE; FEMALE; HUMAN; HYPERTENSION; INTERMETHOD COMPARISON; KIDNEY CARCINOMA; KIDNEY FUNCTION; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NEPHRECTOMY; PARTIAL NEPHRECTOMY; PATIENT SELECTION; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SURGICAL TECHNIQUE; TREATMENT OUTCOME; VASCULAR DISEASE;

AGED; CARCINOMA, RENAL CELL; CREATININE; FEMALE; HUMANS; KIDNEY; KIDNEY FUNCTION TESTS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEPHRECTOMY; PROSPECTIVE STUDIES; RECOVERY OF FUNCTION; URINALYSIS; URINE;

EID: 44149125041     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2008.03.037     Document Type: Article

References (30)

1. Belledegrun A., Tsui K.H., deKernion J.B., and Smith R.B. Efficacy of nephron-sparing surgery for renal cell carcinoma: analysis based on the new 1997 tumor-node-metastasis staging system. J Clin Oncol 17 (1999) 2868-2875
2. Lerner S.E., Hawkins C.A., Blute M.L., et al. Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery. J Urol 155 (1996) 1868-1873
3. Hafez K.S., Fergany A.F., and Novick A.C. Nephron sparing surgery for localized renal cell carcinoma: impact of tumor size on patient survival, tumor recurrence and TNM staging. J Urol 162 (1999) 1930-1933
4. Herr H. Partial nephrectomy for unilateral renal carcinoma and a normal contralateral kidney: 10 year followup. J Urol 161 (1999) 33-34
5. Russo P. Renal cell carcinoma: presentation, staging, and surgical treatment. Semin Oncol 27 (2000) 160-176
6. Hollenbeck B.K., Taub D.A., Miller D.C., et al. National utilization trends of partial nephrectomy for renal cell carcinoma: a case of underutilization. Urol 67 (2006) 254-259
7. Miller D.C., Hollingsworth J.M., Hafez K.S., et al. Partial nephrectomy for small renal masses: an emerging quality of care concern?. J Urol 175 (2006) 853-857
8. Nuttall M., Cathcart P., van der Meulen J., et al. A description of radical nephrectomy practice and outcomes in England: 1995-2002. BJU Int 96 (2005) 58-61
9. Matin S.F., Gill I.S., Worley S., and Novick A.C. Outcome of laparoscopic radical and open partial nephrectomy for the sporadic 4 cm or less renal tumor with a normal contralateral kidney. J Urol 168 (2002) 1356-1360
10. McKiernan J., Simmons R., Katz J., and Russo P. Natural history of chronic renal insufficiency after partial and radical nephrectomy. Urology 59 (2002) 816-820
11. Lau W.K., Blute M.L., Weaver A.L., and Zincke H. Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney. Mayo Clin Proc 75 (2000) 1236-1242
12. Huang W.C., Levey A.S., Serio A.M., et al. Chronic kidney disease after nephrectomy in patients with renal cortical tumors: a retrospective cohort study. Lancet Oncol 7 (2006) 735-740
13. Raj G.V., Iasonos A., Herr H., and Donat S.M. Formulas calculating creatinine clearance are inadequate for determining eligibility for cisplatin based chemotherapy in bladder cancer. J Clin Oncol 24 (2006) 3095-3100
14. Toussaint N.D., Agar J.W.M., and D'Intini V. Calculating glomerular filtration rate in a young man with a large muscle mass. Med J Aust 4 (2006) 221-222
15. Robson C.J., Churchill B.M., and Anderson W. The results of radical nephrectomy for renal cell carcinoma. J Urol 101 (1969) 297-301
16. Talseth T., Fauchald P., Skrede S., et al. Long-term blood pressure and renal function in kidney donors. Kidney Int 29 (1986) 1072-1076
17. Vincenti F., Amend W.J.C., Kaysen G., et al. Long-term renal function in kidney donors. Transplantation 36 (1983) 626-629
18. Williams S.L., Oler J., Jorkansky D.K., et al. Long-term renal function in kidney donors: a comparison of donors and their siblings. Ann Intern Med 105 (1986) 1-8
19. Najarian J.S., Chavers B.M., McHugh L.E., et al. 20 years and more follow-up of living related kidney donors. Lancet 340 (1992) 807-810
20. Miller I.J., Suthanthiran M., Riggio R.R., et al. Impact of renal donation: long-term clinical and biochemical follow-up of living related donors in a single center. Am J Med 79 (1985) 201-208
21. Fehrman-Ekholm I., Norden G., Lennerling A., et al. Incidence of end-stage renal disease among live kidney donors. Transplantation 82 (2006) 1646-1648
22. Ljungberg B., Hanbury D.C., Kuczyk M.A., et al. Renal cell carcinoma guideline. Eur Urol 51 (2007) 1502-1510
23. Becker F., Siemer S., Hack M., et al. Excellent long-term cancer control with elective nephron-sparing surgery for selected renal cell carcinomas measuring more than 4 cm. Eur Urol 49 (2006) 1058-1064
24. Leibovich B.C., Blute M.L., Cheville J.C., et al. Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy. J Urol 171 (2004) 1066-1070
25. Patard J.J., Shvarts O., Lam J.S., et al. Safety and efficacy of partial nephrectomy for all T1 tumors based on an international multicenter experience. J Urol 171 (2004) 2181-2185
26. Russo P., Goetzl M., Simmons R., et al. Partial nephrectomy: the rationale for expanding the indications. Ann Surg Oncol 9 (2002) 680-687
27. Kirkali Z. The motion: open partial nephrectomy is the standard of care for small respectable solid renal masses. Eur Urol 51 (2007) 561-564
28. Stevens L.A., Coresh J., Greene T., and Levey A.S. Assessing kidney function - measured and estimated glomerular filtration rate. N Engl J Med 354 (2006) 2473-2483
29. Levey A.S., Coresh J., Balk E., et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 139 (2003) 137-147
30. Go A., Chertow G., Fan D., et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351 (2004) 1296-1305